Nishimura Yoshito
Internal Medicine, University of Hawaii, Honolulu, USA.
Cureus. 2022 Sep 29;14(9):e29764. doi: 10.7759/cureus.29764. eCollection 2022 Sep.
We describe a case of a 65-year-old man who presented with progressive generalized weakness. He was started on daptomycin for methicillin-resistant Staphylococcus aureus (MRSA) right fifth metatarsal osteomyelitis. Laboratory testing revealed severe hyperkalemia of 7.5 mEq/L (normal range: 3.3-5.1) and acute kidney injury (AKI) stage 1 associated with a substantial elevation in serum creatine kinase (CK). He had been on a high-intensity statin for years, and daptomycin was switched to linezolid, and statin was held as daptomycin-related rhabdomyolysis was suspected. Our case highlights the importance of seeking alternatives to daptomycin for patients on chronic statins.
我们描述了一例65岁男性患者,其表现为进行性全身无力。他因耐甲氧西林金黄色葡萄球菌(MRSA)引起的右第五跖骨骨髓炎开始使用达托霉素治疗。实验室检查发现严重高钾血症,血钾为7.5 mEq/L(正常范围:3.3 - 5.1),以及与血清肌酸激酶(CK)大幅升高相关的急性肾损伤(AKI)1期。他多年来一直服用高强度他汀类药物,由于怀疑达托霉素相关的横纹肌溶解,将达托霉素换为利奈唑胺,并停用了他汀类药物。我们的病例强调了为长期服用他汀类药物的患者寻找达托霉素替代药物的重要性。